rucaparib maintenance for recurrent ovarian carcinoma
Published 5 years ago • 217 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
3:07
rucaparib maintenance and monotherapy for ovarian cancer: trial updates
-
3:29
rucaparib boosts pfs in brca-mutated recurrent ovarian cancer
-
9:31
ariel3: rucaparib as maintenance therapy in recurrent ovarian cancer patients
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
5:11
defining rucaparib’s value in recurrent ovarian cancer
-
6:57
niraparib maintenance for recurrent ovarian cancer
-
3:06
rucaparib maintenance therapy for high-risk ovarian cancer
-
1:13
comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer
-
1:51
brca and rab: prognostic biomarkers in recurrent ovarian cancer
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
4:25
rucaparib: clinical activity in relapsed ovarian cancer
-
5:04
rucaparib and ariel3 – positive results from the phase 3 trial in ovarian cancer patients
-
0:44
nice recommendation: maintenance treatment for ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
4:20
rucaparib explored for high-risk ovarian cancer
-
1:42
dr. ledermann on rucaparib maintenance in ovarian cancer
-
1:50
niraparib as maintenance for platinum-sensitive ovarian cancer - results from engot-ov16/nova trial
-
1:29
dr. monk on the fda approval of maintenance rucaparib in ovarian cancer
-
3:11
rucaparib in recurrent ovarian cancer: ariel3 trial